Hospital
University Hospitals Conneaut Medical Center
University Hospitals Conneaut Medical Center was paid $5.65M by Medicaid between Jan 2018 and Dec 2024, across 132 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.
33Billing provider infoUNIVERSITY HOSPITALS CONNEAUT MEDICAL CENTER
CONNEAUT, OH 44030
CONNEAUT, OH 44030
33aNPI1902996119assigned 10/16/2006
33bProvider typeCritical Access Hospital
28Total paid$5.65M
24GClaims130,569
24DCodes billed132
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Ohio
Rank by total paid#13 of 26
Median peer was paid$5.33M
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,884 | $289K | |
| 2019 | 8,340 | $297K | |
| 2020 | 8,468 | $402K | |
| 2021 | 12,291 | $527K | |
| 2022 | 12,994 | $573K | |
| 2023 | 48,943 | $2.03M | |
| 2024incomplete | 31,649 | $1.53M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 13,011 | 11,807 | $1.72M |
| 96361 | Intravenous infusion, hydration; each additional hour | 14% | 2,577 | 1,976 | $800K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 4,556 | 3,896 | $686K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10% | 4,850 | 4,188 | $581K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.1% | 990 | 833 | $290K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.2% | 849 | 657 | $236K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.7% | 1,344 | 882 | $209K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.7% | 559 | 442 | $153K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.6% | 455 | 352 | $92K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.6% | 429 | 265 | $90K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.6% | 1,083 | 319 | $88K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.4% | 330 | 252 | $82K |
120 more codes
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.4% | 836 | $79K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 745 | $63K |
| 80053 | Comprehensive metabolic panel | <1% | 7,971 | $55K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 418 | $46K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 279 | $40K |
| G0378 | Hospital observation service, per hour | <1% | 780 | $37K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,528 | $33K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 216 | $28K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 270 | $21K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,295 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,893 | $19K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 446 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,583 | $16K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 664 | $14K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,390 | $14K |
| 84484 | <1% | 4,589 | $8K | |
| 82805 | <1% | 255 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 381 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,735 | $7K |
| 80061 | Lipid panel | <1% | 381 | $6K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 331 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 105 | $4K |
| 12001 | <1% | 14 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,193 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 150 | $4K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,199 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 44 | $3K |
| 71250 | <1% | 49 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,178 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,572 | $2K |
| 94664 | <1% | 300 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 922 | $2K |
| 85027 | <1% | 826 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,205 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,018 | $2K |
| 83605 | <1% | 2,613 | $2K | |
| 96376 | <1% | 466 | $2K | |
| 87081 | <1% | 167 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 19 | $2K |
| 73630 | <1% | 273 | $2K | |
| 83735 | <1% | 1,296 | $2K | |
| 73610 | <1% | 188 | $2K | |
| 81001 | <1% | 2,449 | $2K | |
| 96367 | <1% | 20 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 148 | $1K |
| 82947 | <1% | 1,020 | $1K | |
| 73130 | <1% | 149 | $1K | |
| 82607 | <1% | 42 | $1K | |
| 80346 | <1% | 75 | $1K | |
| 81003 | <1% | 2,356 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 76 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 44 | $1K |
| 97161 | <1% | 30 | $969.93 | |
| 86140 | <1% | 136 | $781.37 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 21 | $725.59 |
| 73564 | <1% | 28 | $676.95 | |
| 84702 | <1% | 297 | $658.05 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 979 | $653.34 |
| 85610 | <1% | 1,944 | $569.57 | |
| 80361 | <1% | 75 | $560.82 | |
| 82077 | <1% | 433 | $512.68 | |
| 73030 | <1% | 65 | $495.87 | |
| 83880 | <1% | 605 | $463.22 | |
| 87449 | <1% | 209 | $431.94 | |
| 83690 | <1% | 1,502 | $270.79 | |
| 81025 | <1% | 1,062 | $260.55 | |
| 87040 | <1% | 831 | $246.67 | |
| 87077 | <1% | 120 | $240.79 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,809 | $235.77 |
| 87186 | <1% | 125 | $230.00 | |
| 85379 | <1% | 694 | $219.04 | |
| J3490 | Unclassified drugs | <1% | 352 | $213.98 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 47 | $185.22 |
| 73110 | <1% | 27 | $179.07 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 532 | $178.31 |
| 90715 | <1% | 16 | $166.19 | |
| 80076 | <1% | 125 | $138.74 | |
| 87634 | <1% | 100 | $138.66 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 122 | $106.84 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 379 | $85.20 |
| 84132 | <1% | 130 | $76.73 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,764 | $74.35 |
| 80143 | <1% | 117 | $73.84 | |
| 85652 | <1% | 67 | $68.49 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 525 | $51.11 |
| 87075 | <1% | 473 | $44.99 | |
| 82550 | <1% | 66 | $39.84 | |
| 80179 | <1% | 86 | $36.92 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 416 | $34.09 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,169 | $27.14 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 18 | $22.50 |
| 82570 | <1% | 62 | $18.47 | |
| 85018 | <1% | 115 | $17.10 | |
| 94760 | <1% | 588 | $14.45 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 86 | $11.17 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 207 | $10.08 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 164 | $8.24 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 180 | $5.33 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 76 | $4.76 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 138 | $2.74 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 63 | $0.72 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 47 | $0.68 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,565 | $0.00 |
| 84295 | 0% | 84 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 69 | $0.00 |
| 82248 | 0% | 93 | $0.00 | |
| 80365 | 0% | 17 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 15 | $0.00 |
| 80354 | 0% | 17 | $0.00 | |
| 80373 | 0% | 17 | $0.00 | |
| 82330 | 0% | 101 | $0.00 | |
| 82435 | 0% | 90 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 1,868 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 27 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 116 | $0.00 |
| 73552 | 0% | 15 | $0.00 | |
| 84703 | 0% | 12 | $0.00 | |
| 80368 | 0% | 17 | $0.00 | |
| 76377 | 0% | 12 | $0.00 | |
| 80358 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHILLERO, ANTHONY (DIRECTOR, FP&A)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.